— Dr. Oliver Ratcliffe
ALAMEDA Island, California, USA, September 20, 2022 /EINPresswire.com/ — Clue Genetics Inc. (Clue) announced the appointment of Mr. Ryan Bush to its Advisory Board. Ryan is a seasoned executive with 30 years of experience across sectors in both large and small companies. He has a background in finance and operations and has previously held senior positions at Mellon Ventures, Eaton Corporation and Koch Industries. Ryan has extensive experience in fundraising and closing deals and will assist the Clue Genetics board and leadership team in securing future capital rounds. Dr. Oliver Ratcliffe, Executive Chairman of Clue, commented: “We are delighted to have someone with Ryan’s experience and connections on our advisory team; we look forward to having him work with us to help negotiate and structure future deals.”
About Clue Genetics: Clue Genetics is a leader in fungal genomics and owns a large and diverse proprietary collection of microbial strains. The firm uses metabolic genomic and synthetic biology approaches to develop fungal-derived molecules for a wide range of applications, including new treatments for disease, pollution control, and more sustainable inputs for agriculture.
Oliver J. Ratcliffe
Clu Genetics Inc.